title: Treatment of acute myeloid leukaemia.
abstract: Acute myeloid leukaemia is a heterogeneous disease that occurs in all age groups but peaks in older age at around a median of 69-70 years where it has a frequency of 13-15/100,00/annum. With the changing demographics, the number of cases will increase in line with the older population. As the only treatment with curative intent is intensive chemotherapy, this presents an immediate therapeutic challenge for the majority of the disease.
authors.affiliation: Department of Haematology, Cardiff University, Cardiff, UK.
authors.forename: Alan K
authors.initials: AK
authors.lastname: Burnett
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D006801:Humans; D015470:Leukemia, Myeloid, Acute; D012074:Remission Induction; D016896:Treatment Outcome
keywords: Acute myeloid leukaemia (AML); chemotherapy; leukaemia; treatment